Professional Documents
Culture Documents
Drug Study Uti
Drug Study Uti
AMPICILLIN/ Antibiotic 8-14 g/day Interferes Skin and structure Do not use CNS: lethargy, Assess patient of
SULBACTAM with cell wall infections solution in hallucinations, previous
replication of infants, children anxiety, depression, sensitivity
Brand Name susceptible Intra abdominal less than 4 years twitching, coma, reaction to
organisms infections of age, seizures penicillins or
Unasyn pregnancy, in GI: nausea, cephalosporins
Pneumonia liver or kidney vomiting, diarrhea, Assess patient
failure, and in increased AST, ALT, for signs and
Gynecologic those treated abdominal pain, symptoms of
infections with disulfiram or glositis, colitis, infection
metronidazole pseudomembranous Complete C&S
Soft tissue colitis before
infections GU: oliguria, beginning
proteinuria, product therapy
Otitis media hematuria, vaginitis, to identify if
moniliasis, correct
Sinusitis glomerulonephritis, treatment has
dysuria been initiated
Meningitis HEMA: anemia, Assess for
increased bleeding allergic
Septicemia time, bone marrow reactions
depression, Monitor blood
granulocytopenia, studies
leukopenia, Monitor
eosinophilia electrolytes
SYST: anaphylaxis, Assess bowel
serum sickness, pattern daily
toxic epidermal Monitor for
necrolysis, Stevens- bleeding
Johnson syndrome Assess for
superinfection